The Opportunity

insitro is using machine learning to yield entirely new, clinically actionable insights into critical unmet needs for patients. We aim to "go fast and improve things" across the entire drug development process from platform to pipeline to patients and back again.

The (Senior) Medical Director, Physician and Translational Lead for Metabolism is a unique opportunity to directly improve patients' lives by leading clinical trial design and execution for new therapies and diagnostics for metabolic diseases. We are devoted to the effort to make clinical trials more helpful for patients and for drug developers. We believe that by focusing on what's best for patients, we can do what's best for drug development at the same time.

You will develop, execute, and oversee rapid clinical trials of diverse therapeutic modalities and companion digital and laboratory biomarkers from first-in-human through proof-of-concept. The number of drug developers applying machine learning to diagnostic and drug development is increasing. Therefore, you will implement innovative clinical trials of new therapies and diagnostics and influence how machine learning-informed drug development advances at the same time. After all, patients are fighting debilitating, life-threatening conditions right now. We have to do better.

You will report directly to the Chief Medical Officer. This role can be either onsite (3 days per week) in our South San Francisco office or hybrid (~one week per month) in the office. Additional travel will be needed: to clinical sites for site initiation and onboarding; to relevant medical conferences; and to the clinical research organizations we will partner with.

Responsibilities

  • Build and lead the clinical function for metabolic disease. This will include diverse therapeutic and diagnostic modalities (e.g., small molecules, biologics, oligonucleotides, novel laboratory and digital biomarkers), developed internally and in-licensed; and all development stages (focus is IND through clinical proof-of-concept).
  • As the metabolic diseases clinical expert for the company, use your expertise to bring clinical data to bear directly on our research and computation and vice versa. This includes: playing a key strategic role in integration of patient perspective to inform disease modeling and drug discovery efforts, partnering with colleagues in data science & machine learning (DSML) and corporate development to identify critical data assets and/or commission the generation of data for biomarker discovery in metabolic diseases, and collaborating with DSML colleagues to define machine learning (ML) models for clinical data to inform our understanding of patient trajectory and patient subpopulations and to identify novel endpoints for clinical trials.
  • Design and oversee innovative, accelerated clinical trial strategies, including ML-enabled trials, to enable objective, data-driven go-no-go decisions and shorten the development cycle in the face of an evolving regulatory landscape.
  • Partner with clinical operations to build a network of clinical trial sites, attract key investigators, and select effective clinical research organizations.
  • Serve as global clinical/development lead and medical monitor for the initial metabolic diseases clinical-stage asset(s); over time, opportunity to help build and manage a focused, effective team of global clinical leads to match our growing pipeline.
  • Be accountable for the end-to-end clinical development plan, target product profile, clinical components of IND, protocol and amendments, clinical study reports, regulatory information requests, clinical trial translational biomarker plan, and statistical analysis plan.
  • In partnership with other key colleagues, oversee clinical manuscripts, abstracts and presentations, presentation of clinical programs internally and externally at investigator meetings, advisory boards, clinical trial sites, and clinical components of regulatory interactions.

 

About You

  • MD or MD-PhD with residency and fellowship training in a specialty related to metabolic diseases (e.g., gastrointestinal/liver disease, obesity, endocrinology). Active US board certification preferred. Technical experience in genetics, molecular biology, metabolism, cellular biology, or equivalent preferred.
  • 5-10+ years' experience in clinical development with at least 3-5+ years in biotechnology or pharmaceutical settings leading the design and execution of clinical trials for metabolic diseases from first-in-patient through proof-of-concept. Managed other global clinical leads in the same is preferred for senior director level.
  • Experience working with patients, patient data, and biomarker data sets such as proteomics, metabolomics, transcriptomics, imaging.
  • Established track record of original contributions to clinical trials, translational medicine, or clinical practice including original publications and/or presentations.
  • Key competencies: basic and translational science and physiology of metabolic diseases, patient care, clinical trial design and execution, clinical pharmacology, biostatistics, clinical operations, good clinical practice, regulatory science, applications of computation to medicine.
  • Capable of communicating and collaborating with people of diverse backgrounds and job functions, including a track record of collaborating with diverse stakeholders, including other clinical, translational, computational, and life scientists.
  • Strong interpersonal skills that motivate others to excel and achieve their very best.

 

Compensation & Benefits at insitro

Our target starting salary for successful US-based applicants for this role is $260,000 - $350,000. To determine starting pay, we consider multiple job-related factors including a candidate's skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.

This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.

 

In addition, insitro also provides our employees:

  • 401(k) plan with employer matching for contributions
  • Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees on our base plans), as well as mental health and well-being support
  • Open, flexible vacation policy
  • Paid parental leave
  • Quarterly budget for books and online courses for self-development
  • Support to attend professional conferences that are meaningful to your career growth and development
  • New hire stipend for home office setup
  • Monthly cell phone & internet stipend
  • Access to free onsite baristas and cafe with daily lunch and breakfast
  • Access to free onsite fitness center
  • Commuter benefits

 

insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.

We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams–grounded in a wide range of expertise and life experiences–and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.

About insitro
 
insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience, oncology and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.

Apply for this Job

* Required
resume chosen  
Dropbox Google Drive
(File types: pdf, doc, docx, txt, rtf)
Cancel
cover_letter chosen  
Dropbox Google Drive
(File types: pdf, doc, docx, txt, rtf)
Cancel

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in insitro’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.

Our system has flagged this application as potentially being associated with bot traffic. Please turn off any VPNs, clear your browser cache and cookies, or try submitting your application in a different browser. If this issue persists, please reach out to our support team via our help center.
Please complete the reCAPTCHA above.